Eczema Patients Have Lost Faith In Treatment: Survey

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2022-09-13 HKT 20:53

Share this story

facebook

  • Eczema patients have lost faith in treatment: survey

A international survey has found that only 37 percent of eczema patients in the city are working on treatment plans with doctors, while two-thirds have lost hope.

GlobalSkin, an international alliance of dermatology patient organisations, initiated the study covering 330 eczema patients in the SAR, South Korea and Australia in August, with one-third of the respondents in Hong Kong.

Dermatologist Dr Johnny Chan said on Tuesday that the proportion of patients in the city seeking medical advice is “very low”.

He said more than 90 percent of them are being treated by public practitioners, but strained medical resources due to the Covid-19 pandemic have delayed their treatment.

“The queue time of every [eczema] treatment will be two to three years at the moment," he said, adding that does not taken into account the impact Covid has had on waiting times even longer.

“While they are waiting, they think the treatments will not be helping them, and may lose the faith in treatment. They think it’s just incurable, they don’t want to have any treatment anymore,” Chan said.

“Public doctors have a limited time to see a lot of patients every day."

But for moderate to severe cases, he said, "they need some more time for explanations about the disease nature: to have a more tailor-made treatment plan for the patients, and to explain any possible side effects and the way to avoid these side effects.”

Chan added that less than 10 percent of eczema sufferers had sought treatment from the private sector. He said high costs was "very much an issue" here, with 72 percent of patients saying the heavy financial burden had deterred them from visiting doctors.

Dr Marco Ho, who chairs the Hong Kong Allergy Association, said when treatment is delayed, a patients’ immune system further deregulates and their conditions worsen, hence their expectations in consultations can be over-optimistic.

“Sometimes you don’t have the best-matched medication treatment as well as therapies. They have a whole lot of ideas and their own personal belief, so end up when we say ‘control’, they say ‘cure’; when we say ‘short-term gain’, they want a ‘long-term' remission,” he said.

“At times we even think the patient needs hospitalisation [but] they can't afford to stop their work or school.”

To clear up such misinterpretations and handle mental problems when patients are suffering from skin conditions, the allergy association and a concern group under the Hong Kong Health Care Alliance launched a free online counseling service on Tuesday that will run for three months.

RECENT NEWS

SUNMI Technology Is Officially Listed On The Main Board Of HKEX

SUNMI Technology Group Co., Ltd, a Business IoT (BIoT) leader, was officially listed on the Main Board of the Hong Kong... Read more

Can AI-Native Infrastructure Finally Eliminate The Friction Within Cross-Border Payments?

What is stopping businesses from fully tapping a US$336 billion cross-border payments opportunity? Ask the merchants tr... Read more

HKMA Cargox Pilot Brings 21 Banks To Boost SME Trade Finance Via Data Sharing

The Hong Kong Monetary Authority (HKMA) has launched the HKMA Cargox pilot programme, partnering with 21 banks to digit... Read more

Krakens Parent Acquires Reap In US$600M Deal To Expand Stablecoin Payments In Asia

Payward, the parent company of cryptocurrency exchange Kraken, is acquiring Hong Kong-based payments infrastructure fir... Read more

XTransfer Files For Hong Kong IPO, Seeking US$186 Million

Chinese B2B cross-border payments company XTransfer has filed for an IPO in Hong Kong to raise US$186 million. The comp... Read more

HSBC Rolls Out Privé World Legend Mastercard To Hong Kong Clients

HSBC Hong Kong has launched the HSBC Privé World Legend Mastercard, becoming the first bank in the Asia Pacific region... Read more